CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma.
Saved in:
| Title: | CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma. |
|---|---|
| Authors: | Brancato L; ElmediX NV, Esperantolaan 4, 3001 Leuven, Belgium., Osok D; ElmediX NV, Esperantolaan 4, 3001 Leuven, Belgium.; KAVI Institute of Clinical Research (KAVI-ICR), Faculty of Health Sciences, University of Nairobi, Nairobi P.O. Box 19676-00202, Kenya.; Laboratory of Cell Biology and Histology, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium., Van den Bossche L; ElmediX NV, Esperantolaan 4, 3001 Leuven, Belgium., Van Cutsem E; Department of Digestive Oncology, University Hospital Gasthuisberg and University of Leuven (KUL), 3000 Leuven, Belgium., Bates SE; Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center, New York, NY 10032, USA.; James J. Peters VA Medical Centre, Bronx, NY 10468, USA., Van den Bossche J; ElmediX NV, Esperantolaan 4, 3001 Leuven, Belgium., Bogers J; ElmediX NV, Esperantolaan 4, 3001 Leuven, Belgium.; Laboratory of Cell Biology and Histology, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium. |
| Source: | Cancers [Cancers (Basel)] 2025 Dec 05; Vol. 17 (24). Date of Electronic Publication: 2025 Dec 05. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers17243902 |
